FDA grants ODD status to Zai Lab’s lung cancer treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
Macau Business21h
Corero Network Security Enhances UK Dedicated Servers’ DDoS Defense with High-Performance Upgrade
UK Dedicated Servers Strengthens Partnership with Corero as First EMEA Adopter of New Adaptive NTD3400 DDoS Solution. MARLBOROUGH, Mass., Jan. /PRNewswire/ — Corero Net ...